ORIENT BIO Inc. (KRX:002630)
663.00
-3.00 (-0.45%)
Dec 5, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY undefined | FY undefined | FY undefined | FY undefined | FY undefined | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | NaN - NaN |
| Biomaterials | 20.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biomaterials Growth | -5.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biological Materials, Etc | 9.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biological Materials, Etc Growth | 36.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Animals Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Animals Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Animals | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Animals Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Resentment | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Resentment Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY undefined | FY undefined | FY undefined | FY undefined | FY undefined | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | NaN - NaN |
| South Korea | 29.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 4.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 227.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 162.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|